NIH-funded research R01 grant

Investigating how rare genetic variations affect the risk of obsessive-compulsive disorder.

Official title: 2/2 Rare Genetic Variation and Risk for Obsessive Compulsive Disorder

Funded at Univ of North Carolina Chapel Hill · NIH-10974472 · Data updated 2026-11-12

This study is looking at how rare genetic changes might affect the chances of developing obsessive-compulsive disorder (OCD) by comparing the genes of over 5,100 people with OCD to those of 3,000 people without it, hoping to find clues that could help us better understand and treat the condition.

More Obsessive-Compulsive Disorder research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startDecember 15, 2020
Project endOctober 31, 2025
Funding year2025
Award (this year)$198,263
NIH project number5R01MH124675-05
Project IDNIH-10974472 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with obsessive-compulsive disorder, particularly those aged 0-11 years.

Less likely to help

Patients without a diagnosis of obsessive-compulsive disorder or those outside the specified age range may not benefit from this research.

What this research studies

This research aims to explore the role of rare genetic variations in all protein-coding genes and their influence on the risk of developing obsessive-compulsive disorder (OCD). By utilizing whole exome sequencing (WES), the study will analyze genetic data from over 5,100 OCD patients and 3,000 matched controls from Sweden and Norway. The goal is to identify specific genetic risk factors and pathways associated with OCD, which could lead to improved understanding and treatment options for the disorder.

Why it matters

Potential benefit: If successful, this research could lead to better detection, prevention, and treatment strategies for obsessive-compulsive disorder.

How similar studies have gone: Previous research in other psychiatric disorders using whole exome sequencing has shown success in identifying genetic risk factors, suggesting a promising approach for OCD as well.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Crowley, James Joseph — Univ of North Carolina Chapel Hill
  • Study coordinator: Crowley, James Joseph

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.